Virtual Event
Management of FLT3-Mutated AML: What’s New in 2026?
February 23 @ 7:00 pm - 8:30 pm EST
Virtual Event
We invite you to join a discussion about the management of FLT3-mutated AML and what’s new in 2026.
The discussion will cover the impact of newly available Quizartinib on Canadian practice, and recent advances in FLT3-ITD MRD testing.
When: Monday, February 23, 2026 at 7:00 Pm EST.
Where: Zoom – link will be provided upon registration.
Faculty:
Julie Bergeron, Hôpital Maisonneuve-Rosemont, Montréal QC
Hubert Tsui, Sunnybrook Health Sciences Centre, Toronto ON